⚠ Regulatory Alert Drug residues in shrimp exports have triggered a sweeping directive from CDSCO, putting state drug
June 4, 2026
CDSCO Directs All Drug Manufacturers to Establish Pharmacovigilance Systems Under Schedule M
4th June, 2026 Drugs Controller General of India (DCGI), issued a formal circular directing all drug manufacturers and all stakeholders
May 23, 2026
India brings Pregabalin under Schedule H1
The Ministry of Health and Family Welfare has formally added the widely used nerve-pain drug Pregabalin to Schedule H1 of
Central Drugs Standard Control Organisation (CDSCO) in its latest notification has moved to tighten oversight of the booming cosmetics industry
The Central Drugs Standard Control Organization (CDSCO), operating under the Directorate General of Health Services, Government of India, has issued





